<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">41031153</PMID><DateCompleted><Year>2025</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Safety and effectiveness of apixaban use for stroke prevention during Ramadan fasting (the API-RAM study).</ArticleTitle><Pagination><StartPage>1565094</StartPage><MedlinePgn>1565094</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1565094</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2025.1565094</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Patients receiving anticoagulation for atrial fibrillation (AF) are required to consult their doctor before starting Ramadan fasting to get their authorization for fasting and adapt their treatment. More often, a once-daily regimen is proposed to facilitate their intake schedule. Apixaban, a direct oral anticoagulant, prescribed twice daily with an optimal benefit/risk ratio in numerous situations, has very limited data regarding its use during Ramadan.</AbstractText><AbstractText Label="AIM" NlmCategory="UNASSIGNED">The aim of this study was to evaluate the safety and the efficacy of apixaban for stroke prevention in AF patients during the month of Ramadan.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">An observational, multicentric study was performed in Tunisia during two consecutive years during the specific month of Ramadan. The API-RAM study included AF patients who were on apixaban and fasted at least 10&#xa0;days. Efficacy was defined by the absence of ischemic events, and safety was established by classifying bleeding events using the BARC (Bleeding Academic Research Consortium) classification during the study period.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 257 patients were included in our study. No ischemic events were reported during the study period. Minor bleeding events were reported in only 12 patients (4.7%), with no major bleeding event. Based on multivariate analysis, independent predictors for the bleeding risk of our population were as follows: smoking, history of hypertension, and creatinine clearance.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Apixaban seems to be safe and effective for the prevention of the thromboembolic episode in AF patients during Ramadan fasting. Larger studies such as randomized clinical trials are necessary to confirm these results.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Ghrab, Gargouri, Addad, Cheikhrouhou, Jabeur, Charfeddine, Bahloul, Triki, Ellouze, Abidi, Mallek, Triki, Abdessalem, Elalamy and Abid.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ghrab</LastName><ForeName>Aiman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hedi Chaker University Hospital Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gargouri</LastName><ForeName>Rania</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hedi Chaker University Hospital Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Addad</LastName><ForeName>Faouzi</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hannibal Clinic, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheikhrouhou</LastName><ForeName>Anis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hedi Chaker University Hospital Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jabeur</LastName><ForeName>Mariem</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hedi Chaker University Hospital Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charfeddine</LastName><ForeName>Selma</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hedi Chaker University Hospital Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahloul</LastName><ForeName>Amine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hedi Chaker University Hospital Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Triki</LastName><ForeName>Zied</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hedi Chaker University Hospital Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellouze</LastName><ForeName>Tarek</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hedi Chaker University Hospital Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abidi</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Hannibal Clinic, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallek</LastName><ForeName>Souad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hedi Chaker University Hospital Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Triki</LastName><ForeName>Faten</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hedi Chaker University Hospital Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdessalem</LastName><ForeName>Salem</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinic Pasteur Tunis, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elalamy</LastName><ForeName>Ismail</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Hematology Department, American Hospital of Paris, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fondation UPM des Sciences de la Sant&#xe9;, Marrakesh, Morocco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics, Gynecology and Perinatal Medicine, Sechenov University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abid</LastName><ForeName>Leila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hedi Chaker University Hospital Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ramadan</Keyword><Keyword MajorTopicYN="N">anticoagulants</Keyword><Keyword MajorTopicYN="N">apixaban</Keyword><Keyword MajorTopicYN="N">atrial fibrillation</Keyword><Keyword MajorTopicYN="N">fasting</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>10</Month><Day>1</Day><Hour>12</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>10</Month><Day>1</Day><Hour>5</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41031153</ArticleId><ArticleId IdType="pmc">PMC12476992</ArticleId><ArticleId IdType="doi">10.3389/fphar.2025.1565094</ArticleId><ArticleId IdType="pii">1565094</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Addad F., Amami M., Ibn Elhadj Z., Chakroun T., Marrakchi S., Kachboura S. (2014). Does ramadan fasting affect the intensity of acenocoumarol-induced anticoagulant effect? Br. J. Haematol. 166 (5), 792&#x2013;794. 10.1111/bjh.12897</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.12897</ArticleId><ArticleId IdType="pubmed">24749553</ArticleId></ArticleIdList></Reference><Reference><Citation>
Agrawal A., Kerndt C. C., Manna B. (2024). &#x201c;Apixaban,&#x201d; in 
<i>StatPearls. Treasure Island</i>
, FL: StatPearls Publishing. Available online at: http://www.ncbi.nlm.nih.gov/books/NBK507910/(Accessed: January 4, 2025).</Citation></Reference><Reference><Citation>Akhtar A. M., Ghouri N., Chahal C. A. A., Patel R., Ricci F., Sattar N., et al. (2022). Ramadan fasting: recommendations for patients with cardiovascular disease. Heart 108 (4), 258&#x2013;265. 10.1136/heartjnl-2021-319273</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2021-319273</ArticleId><ArticleId IdType="pmc">PMC8819657</ArticleId><ArticleId IdType="pubmed">33990414</ArticleId></ArticleIdList></Reference><Reference><Citation>AlAyoubi F. (2021). The effect of ramadan fasting on oral anticoagulant: experience of tertiary academic hospital. Ann. Rev. and Res. 6 (3). 10.19080/ARR.2021.06.555688</Citation><ArticleIdList><ArticleId IdType="doi">10.19080/ARR.2021.06.555688</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Ghumlas A. K. (2024). Ramadan intermittent fasting is associated with improved anticoagulant activity among healthy people: a case&#x2013;control study. Sci. Rep. 14 (1), 13855. 10.1038/s41598-024-64582-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-64582-8</ArticleId><ArticleId IdType="pmc">PMC11180170</ArticleId><ArticleId IdType="pubmed">38879576</ArticleId></ArticleIdList></Reference><Reference><Citation>Almulhem M., Susarla R., Alabdulaali L., Khunti K., Karamat M. A., Rasiah T., et al. (2020). The effect of ramadan fasting on cardiovascular events and risk factors in patients with type 2 diabetes: a systematic review. Diabetes Res. Clin. Pract. 159, 107918. 10.1016/j.diabres.2019.107918</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2019.107918</ArticleId><ArticleId IdType="pubmed">31711857</ArticleId></ArticleIdList></Reference><Reference><Citation>AlShoaibi N., Al Harbi M., Modaimegh H., Al Qubbany A., Al Saif S., Connolly D. L., et al. (2021). Use of NOACS in high-risk patients with atrial fibrillation in Saudi Arabia: perspectives on improving patient care. Expert Rev. Cardiovasc. Ther. 19 (3), 221&#x2013;236. 10.1080/14779072.2021.1878878</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14779072.2021.1878878</ArticleId><ArticleId IdType="pubmed">33475462</ArticleId></ArticleIdList></Reference><Reference><Citation>Anghel L. A., Farcas A. M., Oprean R. N. (2019). An overview of the common methods used to measure treatment adherence. Med. Pharm. Rep. 92 (2), 117&#x2013;122. 10.15386/mpr-1201</Citation><ArticleIdList><ArticleId IdType="doi">10.15386/mpr-1201</ArticleId><ArticleId IdType="pmc">PMC6510353</ArticleId><ArticleId IdType="pubmed">31086837</ArticleId></ArticleIdList></Reference><Reference><Citation>Batarfi A., Alenezi H., Alshehri A., Balelah S., Kazim H., Algthami M., et al. (2021). Patient-guided modifications of oral anticoagulant drug intake during ramadan fasting: a multicenter cross-sectional study. J. Thrombosis Thrombolysis 51 (2), 485&#x2013;493. 10.1007/s11239-020-02218-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02218-0</ArticleId><ArticleId IdType="pmc">PMC7886720</ArticleId><ArticleId IdType="pubmed">32666427</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortman L. V., Mitchell F., Naveiro S., P&#xe9;rez Morales J., Gonzalez C. D., Di Girolamo G., et al. (2023). Direct oral anticoagulants: an updated systematic review of their clinical pharmacology and clinical effectiveness and safety in patients with nonvalvular atrial fibrillation. J. Clin. Pharmacol. 63 (4), 383&#x2013;396. 10.1002/jcph.2184</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcph.2184</ArticleId><ArticleId IdType="pubmed">36433678</ArticleId></ArticleIdList></Reference><Reference><Citation>Gajos G., Konieczynska M., Zalewski J., Undas A. (2015). Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk. Cardiovasc. Diabetol. 14, 44. 10.1186/s12933-015-0207-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-015-0207-2</ArticleId><ArticleId IdType="pmc">PMC4432887</ArticleId><ArticleId IdType="pubmed">25928628</ArticleId></ArticleIdList></Reference><Reference><Citation>
Granger C. B., Alexander J. H., McMurray J. J. V., Lopes R. D., Hylek E. M., Hanna M., et al.  (2011). Apixaban <i>versus</i> warfarin in patients with atrial fibrillation. N. Engl. J. Med.
365 (11), 981&#x2013;992. 10.1056/NEJMoa1107039

</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1107039</ArticleId><ArticleId IdType="pubmed">21870978</ArticleId></ArticleIdList></Reference><Reference><Citation>Harskamp R. E., Lucassen W. A. M., Lopes R. D., Himmelreich J. C. L., Parati G., Weert H. C. P. M. v. (2022). Risk of stroke and bleeding in relation to hypertension in anticoagulated patients with atrial fibrillation: a meta-analysis of randomised controlled trials. Acta Cardiol. 77 (3), 191&#x2013;195. 10.1080/00015385.2021.1882111</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00015385.2021.1882111</ArticleId><ArticleId IdType="pubmed">33685380</ArticleId></ArticleIdList></Reference><Reference><Citation>Katada Y., Nakagawa S., Nishimura A., Sato Y. K., Taue H., Matsumura K., et al. (2019). Effects of fasting on warfarin sensitivity index in patients undergoing cardiovascular surgery. Eur. J. Clin. Pharmacol. 75 (4), 561&#x2013;568. 10.1007/s00228-018-2592-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-018-2592-4</ArticleId><ArticleId IdType="pubmed">30460405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B. H., Joo Y., Kim M. S., Choe H. K., Tong Q., Kwon O. (2021). Effects of intermittent fasting on the circulating levels and circadian rhythms of hormones. Endocrinol. Metabolism 36 (4), 745&#x2013;756. 10.3803/EnM.2021.405</Citation><ArticleIdList><ArticleId IdType="doi">10.3803/EnM.2021.405</ArticleId><ArticleId IdType="pmc">PMC8419605</ArticleId><ArticleId IdType="pubmed">34474513</ArticleId></ArticleIdList></Reference><Reference><Citation>Langsted A., Nordestgaard B. G. (2018). Smoking is associated with increased risk of major bleeding: a prospective cohort study. Thrombosis Haemostasis 119, 39&#x2013;47. 10.1055/s-0038-1675798</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1675798</ArticleId><ArticleId IdType="pubmed">30597498</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehran R., Rao S. V., Bhatt D. L., Gibson C. M., Caixeta A., Eikelboom J., et al. (2011). Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation 123 (23), 2736&#x2013;2747. 10.1161/CIRCULATIONAHA.110.009449</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.110.009449</ArticleId><ArticleId IdType="pubmed">21670242</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirghani H. O., Faisal A. F. F., Salman A. W., Hussain G. A., Abdulaziz A. E., Muflih A. M., et al. (2023). Adherence to antidiabetic medication during the month of ramadan among diabetes mellitus patients in the Kingdom of Saudi Arabia. J. Adv. Zoology 44 (5), 747&#x2013;755. 10.53555/jaz.v44i5.3110</Citation><ArticleIdList><ArticleId IdType="doi">10.53555/jaz.v44i5.3110</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouali S., Ben Halima A., Chabrak S., Chettaoui R., Ben Halima M., Haggui A., et al. (2021). Epidemiological characteristics, management, and outcomes of atrial fibrillation in TUNISIA: results from the national Tunisian registry of atrial fibrillation (NATURE&#x2010;AF). Clin. Cardiol. 44 (4), 501&#x2013;510. 10.1002/clc.23558</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23558</ArticleId><ArticleId IdType="pmc">PMC8027580</ArticleId><ArticleId IdType="pubmed">33704830</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;aloza-Mart&#xed;nez E., Moreno G., Aroca-Crevill&#xe9;n A., Huertas S., Vicent L., Rosillo N., et al. (2022). Circadian rhythms in thrombosis and atherothrombotic events. Front. Bioscience-Landmark 27 (2), 51. 10.31083/j.fbl2702051</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.fbl2702051</ArticleId><ArticleId IdType="pubmed">35226994</ArticleId></ArticleIdList></Reference><Reference><Citation>Rad M. S. (2023). Ramadan fasting as a goal-pursuit: why people fast, and how motives affect their experience. Motivation Sci. 9, 327&#x2013;339. 10.1037/mot0000310</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/mot0000310</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosca C. I., Sharma A., Nisulescu D. D., Otiman G., Duda-Seiman D. M., Morariu S. I., et al. (2023). Prevalence of cardio-embolic brain complications in permanent and paroxysmal atrial fibrillation patients. Healthcare 11 (2), 175. 10.3390/healthcare11020175</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare11020175</ArticleId><ArticleId IdType="pmc">PMC9858915</ArticleId><ArticleId IdType="pubmed">36673543</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandrini L., Ieraci A., Amadio P., Zar&#xe0; M., Barbieri S. S. (2020). Impact of acute and chronic stress on thrombosis in healthy individuals and cardiovascular disease patients. Int. J. Mol. Sci. 21 (21), 7818. 10.3390/ijms21217818</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21217818</ArticleId><ArticleId IdType="pmc">PMC7659944</ArticleId><ArticleId IdType="pubmed">33105629</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoeb M., Fang M. C. (2013). Assessing bleeding risk in patients taking anticoagulants. J. thrombosis thrombolysis 35 (3), 312&#x2013;319. 10.1007/s11239-013-0899-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-013-0899-7</ArticleId><ArticleId IdType="pmc">PMC3888359</ArticleId><ArticleId IdType="pubmed">23479259</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridharan K., Al Banna R., Qader A. M., Husain A. (2021). Does fasting during ramadan influence the therapeutic effect of warfarin? J. Clin. Pharm. Ther. 46 (1), 86&#x2013;92. 10.1111/jcpt.13254</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpt.13254</ArticleId><ArticleId IdType="pubmed">32926452</ArticleId></ArticleIdList></Reference><Reference><Citation>Trabelsi K., Ammar A., Boujelbane M. A., Puce L., Garbarino S., Scoditti E., et al. (2022). Religious fasting and its impacts on individual, public, and planetary health: fasting as a &#x201c;religious health asset&#x201d; for a healthier, more equitable, and sustainable society. Front. Nutr. 9, 1036496. 10.3389/fnut.2022.1036496</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.1036496</ArticleId><ArticleId IdType="pmc">PMC9729557</ArticleId><ArticleId IdType="pubmed">36505246</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrijens B., Heidbuchel H. (2015). Non-vitamin K antagonist oral anticoagulants: considerations on once-vs. twice-daily regimens and their potential impact on medication adherence. EP Eur. 17 (4), 514&#x2013;523. 10.1093/europace/euu311</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euu311</ArticleId><ArticleId IdType="pubmed">25694538</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Chang A. R., Inker L. A., McAdams-DeMarco M., Grams M. E., Shin J. I. (2023). Associations of apixaban dose with safety and effectiveness outcomes in patients with atrial fibrillation and severe chronic kidney disease. Circulation 148 (19), 1445&#x2013;1454. 10.1161/CIRCULATIONAHA.123.065614</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.123.065614</ArticleId><ArticleId IdType="pmc">PMC10840683</ArticleId><ArticleId IdType="pubmed">37681341</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz T. (2023). Evaluation of medication adherence of individuals with chronic diseases during ramadan. Ankara Med. J. 23 (3), 344&#x2013;356. 10.5505/amj.2023.70842</Citation><ArticleIdList><ArticleId IdType="doi">10.5505/amj.2023.70842</ArticleId></ArticleIdList></Reference><Reference><Citation>Zghal Mghaieth F., Bonkano A., Boudiche S., Ayari J., Ben Mansour N., Rekik B., et al. (2019). Oral anticoagulation therapy using acenocoumarol during the month of ramadan: a comparative study between fasting and non-fasting patients. La Tunis. Medicale 97 (10), 1177&#x2013;1186.</Citation><ArticleIdList><ArticleId IdType="pubmed">31691946</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>